Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus

Kidney International

Volumn 49, Issue 1, 1996, Pages 217-221

  Mustonen, Jukka ^a   Partanen, Jukka ^b   Kanerva, Mari ^b   Pietilä, Kari ^b   Vapalahti, Olli ^b   Pasternack, Amos ^b   Vaheri, Antti ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC FACTOR;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CRUSH SYNDROME; FEMALE; GENETIC SUSCEPTIBILITY; HANTAVIRUS; HEMORRHAGIC FEVER; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NEPHROPATHIA EPIDEMICA; PRIORITY JOURNAL; PUUMALA VIRUS;

EID: 0030021593     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.29     Document Type: Article

References (36)

1. LEE HW, VAN DER GROEN G: Hemorrhagic fever with renal syndrome. Prog Med Virol 36:62-102, 1989
2. HEDMAN K, VAHERI A, BRUMMER-KORVENKONTIO M: Rapid diagnosis of hantavirus disease with an IgG avidity assay. Lancet 338:1353-1356, 1991
3. Hantavirus epidemic in Europe, 1993. (Letters to the editor) Lancet 343:114-116, 1994
4. AVSIC-ZUPANC T, XIOA S-Y, STOJANOVIC R, GLIGIC A, VAN DER GROEN G, LEDUC JW: Characterization of Dobrava virus: A hantavirus from Slovenia, Yugoslavia. J Med Virol 38:132-137, 1992
5. NICHOL ST, SPIROPOULOU CF, MORZUNOV S, ROLLIN PE, KSIAZEK TG, FELDMANN H, SANCHEZ A, CHILDS J, ZAKI S, PETERS CJ: Genetic identification of hantavirus associated with an outbreak of acute respiratory illness. Science 262:914-917, 1993
6. DUCHIN JS, KOSTER FT, PETERS CJ, SIMPSON GL, TEMPEST B, ZAKI SR, KSIAZEK TG, ROLLIN PE, NICHOL S, UMLAND ET, MOOLENAAR RL, REEF SE, NOLTE KB, GALLAHER MM, BUTLER JC, BRIEMAN RF: Hantavirus pulmonary syndrome: A clinical description of 17 patients with a newly recognized disease. N Engl J Med 330:949-955, 1994
7. BRUMMER-KORVENKONTIO M, VAHERI A, HOVI T, VON BONSDORFF C-H, VUORIMIES J, MANNI T, PENTTINEN K, OKER-BLOM N, LÄHDEVIRTA J: Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis 141:131-134, 1980
8. MUSTONEN J, BRUMMER-KORVENKONTIO M, HEDMAN K, PASTERNACK A, PIETILÄ K, VAHERI A: Nephropathia epidemica in Finland: A retrospective study of 126 cases. Scand J Infect Dis 26:7-13, 1994
9. SETTERGREN B: Nephropathia epidemica (hemorrhagic fever with renal syndrome) in Scandinavia. Rev Infect Dis 13:736-744, 1991
10. FORSLUND T, SALTEVUO J, ANTTINEN J, AUVINEN S, BRUMMER-KORVENKONTIO M, KORHONEN A, POUTIAINEN M: Complications of nephropathia epidemica: Three cases. J Intern Med 232:87-90, 1992
11. LINDERHOLM M, SETTERGREN B, AHLM C: Swedish fatal case of nephropathia epidemica. Scand J Infect Dis 23:501-502, 1991
12. MUSTONEN J, HELIN H, PIETILÄ K, BRUMMER-KORVENKONTIO M, HEDMAN K, VAHERI A, PASTERNACK A: Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol 41:121-126, 1994
13. VAN YPERSELE DE STRIHOU C, MERY JP: Hantavirus-related acute interstitial nephritis in Western Europe. Expansion of a world-wide zoonosis. Q J Med 73:941-950, 1989
14. COLLAN Y, MIHATCSH MJ, LÄHDEVIRTA J, JOKINEN EJ, ROMPPANEN T, JANTUNEN E: Nephropathia epidemica: Mild variant of hemorrhagic fever with renal syndrome. Kidney Int 49(Suppl 35):S62-S71, 1991
15. TEMONEN M, VAPALAHTI O, HOLTHÖFER H, BRUMMER-KORVENKONTIO M, VAHERI A, LANKINEN H: Susceptibility of human cells to Puumala virus infection. J Gen Virol 74:515-518, 1993
16. COSGRIFF TM: Mechanisms of disease in hantavirus infection: Pathophysiology of hemorrahgic fever with renal syndrome. Rev Infect Dis 13:97-107, 1991
17. NAKAMUARA T, YANAGIHARA R, GIBBS CJ, GADJUSEK DC: Immune spleen cell-mediated protection against fatal Hantaan virus infection in infant mice. J Infect Dis 151:671-679, 1985
18. CHEN L, YANG W: Abnormalities of T cell immunoregulation in hemorrhagic fever with renal syndrome. J Infect Dis 161:1016-1019, 1990
19. OSOBA D, FALK J: HLA-B8 phenotype associated with an increased mixed leukocyte reaction. Immunogenetics 6:425-432, 1978
20. WESTMAN P, KUISMIN T, PARTANEN J, KOSKIMIES S: An HLA-DR typing protocol using group-specific PCR-amplification followed by restriction enzyme digests. Eur J Immunogenet 20:103-109, 1993
21. OTA M, SEKI T, NOMURA N: Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens 38:60-71, 1991
22. KIMURA A, SASAZUKI T: Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique, in HLA 1991, edited by SASAZUKI T, Oxford, Oxford University Press, 1992
23. AWDEH Z, ALPER CA: Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 77:3570-3580, 1980
24. LOKKI M-L, JULIN M: HLA-A,B,C gene and haplotype frequencies in the Finnish population. Tissue Antigens 20:239-250, 1982
25. ALPER CA, AWDEH Z, YUNIS EJ: Conserved, extended MHC haplotypes. Exp Clin Immunogenet 9:58-71, 1992
26. CAMPBELL RD, TROWSDALE J: Map of the human major histocompatibility complex. Immunol Today 14:349-352, 1993
27. TIWARI JL, TERASAKI PI: HLA and Disease Associations. New York, Springer Verlag, 1985
28. LAWLEY TJ, RUSSELL PH, FAUCI AS, KATZ SI, HAMBURGER MI, FRANK MM: Detective Fc-receptor functions associated with the HLA-B8/DR3 haplotype. N Engl J Med 304:185-192, 1981
29. KALLENBERG CGM, KLAASSEN RJL, BEEELEN JM, THE TH: HLA-B8/DR3 phenotype and the primary immune response. Clin Immunol Immunopathol 34:135-140, 1985
30. AMBINDER JM, CHIORAZZI N, GIBOFSKY A, FOTINO M, KUNKEL HG: Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type. Clin Immunol Immunopathol 23:269-274, 1982
31. KIM S, KANG ET, KIM YG, HAN JS, LEE JS, KIM YI, HALL WC, DALRYMPLE JM, PETERS CJ: Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever. Am J Clin Pathol 100:398-400, 1993
32. OLDSTONE MBA: Molecular mimicry and autoimmune disease. Cell 50:819-820, 1987
33. MORGAN BP, WALPORT MJ: Complement deficiency and disease. Immunol Today 12:301-306, 1991
34. ALPER CA, KRUSKALL MS, MARCUS-BAGLEY D, CRAVEN DE, KATZ AJ, BRINK SJ, DIENSTAG JL, AWDEH Z, YUNIS EJ: Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 321:708-712, 1989
35. EGEA E, IGLESIAS A, SALAZAR M: The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J Exp Med 173:531-538, 1991
36. STEEL CM, LUDLAM CA, BEATSON D, PEUTHERER JF, CUTHBERT RJG, SIMMONDS P, MORRISON H, JONES M: HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet i:1185-1188, 1988